Crossmark

The risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors

Crossref DOI link: https://doi.org/10.1186/s12933-020-01162-w

Published Online: 2020-11-06

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ling, Ann Wan-Chin

Chan, Cze-Ci

Chen, Shao-Wei

Kao, Yi-Wei

Huang, Chien-Ying

Chan, Yi-Hsin

Chu, Pao-Hsien
License Information

Text and Data Mining valid from 2020-11-06

Version of Record valid from 2020-11-06
More Information

Article History

Received: 26 May 2020

Accepted: 27 October 2020

First Online: 6 November 2020

Ethics approval and consent to participate

: The study protocol complies with the Declaration of Helsinki and was approved by the Institutional Review Board of the Chang Gung Medical Foundation.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below